173
Views
24
CrossRef citations to date
0
Altmetric
Original Research

A patient preference comparison of Azarga (brinzolamide/timolol fixed combination) vs Cosopt® (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension

, , , &
Pages 623-628 | Published online: 12 Sep 2008

References

  • Alcon Laboratories Inc2003Azopt (brinzolamide) prescribing information
  • BarnebeyHKwokSY2000Patients’ acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice settingClin Ther2212041211110231
  • DayDGSharpeEDAtkinsonMJ2006The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patientsEye205839015933751
  • FechtnerRDRealiniT2004Fixed combinations of topical glaucoma medicationsCurr Opin Ophthalmol15132515021225
  • JampelHDSchwartzGFRobinAL2003Patient preferences for eye drop characteristics: a willingness-to-pay analysisArch Ophthalmol121540612695251
  • KassMAHeuerDKHigginbothamEJ2002The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol1207011312049574
  • KhouriASRealiniTFechtnerRD2007Use of fixed-dose combination drugs for the treatment of glaucomaDrugs Aging2410071618020533
  • KonstasAGMaskalerisGGratsonidisS2000Compliance and viewpoint of glaucoma patients in GreeceEye14752611116698
  • NordmannJPAuzaneauNRicardS2003Vision related quality of life and topical glaucoma treatment side effectsHealth Qual Life Outcomes17514667241
  • NordmannJPDenisPVigneuxM2007Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ) in glaucoma using a qualitative studyBMC Health Serv Res712417683594
  • Merck and Co Inc2005Trusopt (dorzolamide) prescribing information
  • Merck and Co Inc2006Cosopt (dorzolamide 2%/timolol 0.5% fixed combination) prescribing information
  • SilverLH2000Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: results from two multicenter comfort studies. Brinzolamide Comfort Study GroupSurv Ophthalmol44Suppl 2S141510665516
  • StewartWCDayDGStewartJA2004Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjectsEye189051015002017
  • TsaiJCMcClureCARamosSE2003Compliance barriers in glaucoma: a systematic classificationJ Glaucoma12393814520147
  • TsukamotoHNomaHMatsuyamaS2005aThe efficacy and safety of topical brinzolamide and dorzolamide when added to the combination therapy of latanoprost and a beta-blocker in patients with glaucomaJ Ocul Pharmacol Ther211703
  • TsukamotoHNomaHMukaiS2005bThe efficacy and ocular discomfort of substituting brinzolamide for dorzolamide in combination therapy with latanoprost, timolol, and dorzolamideJ Ocul Pharmacol Ther213959